期刊文献+

灯盏花素固体自微乳剂的制备及体外溶出度的评价 被引量:3

Formulation design and evaluation of solid self-microemusifying drug delivery system for breviscapine in vitro
原文传递
导出
摘要 目的研制灯盏花素固体自微乳剂(灯盏花素-SSMEDDS),并考察其体外溶出度。方法通过伪三元相图优化处方工艺,研究自微乳化系统中的油相、乳化剂及助乳化剂的组成和用量,筛选灯盏花素固体自微乳剂的最佳处方,并考察其理化性质及体外溶出度。结果灯盏花素固体自微乳剂的处方中,灯盏花素、GTCC、吐温-20、PEG-400、Transcutol-P、甘露醇的质量比为0.75∶0.69∶10.0∶7.02∶16.36∶65.17;乳滴粒径为34.62 nm;溶出度受溶出介质的影响为:人工肠液>水>人工胃液。结论自微乳剂能够改善灯盏花素的难溶性,固体自微乳剂的制备工艺简单,具有良好的应用前景。 OBJECTIVE To prepare Breviscapine solid self-microemulsifying drug delivery system(Bre-SSMEDDS) and study its dissolution in vitro.METHODS The solubility of breviscapine in different oil,emulsifier and co-emulsifier were measured by ultraviolet spectrophotometry(UV).The breviscapine-SSMEDDS formulation was optimized by analyzing the self-microemulsifying efficiency of various combinations of oil,emulsifier and co-emulsifier and evaluated by pseudo-ternary phase diagram.Meanwhile,the dissolution and the physicochemical properties were assessed.RESULTS The optimum formulations of breviscapine-SSMEDDS were composed of breviscapine,GTCC,Tween 20,PEG-400,Transcutol-P and mannitol at the ratio of 0.75:0.69:10.0:7.02:16.36:65.17.The particle size of breviscapine was 34.62 nm.The dissolution was affected by the type of solvent,phosphate buffer solution(pH6.8)waterartificial gastric juice.CONCLUSION Breviscapine-SSMEDDS can improve the solubility of Breviscapine.The preparation procedure is simple,and has a good applicable prospect.
出处 《华西药学杂志》 CAS CSCD 北大核心 2012年第5期540-543,共4页 West China Journal of Pharmaceutical Sciences
关键词 灯盏花素 固体自微乳 溶出度 Breviscapine Solid self-microemulsion Dissolution
  • 相关文献

参考文献7

二级参考文献74

共引文献306

同被引文献37

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部